Kratom and the FDA — Regulation, Bans, and What's Next

A Regulatory Gray Zone

Kratom exists in one of the strangest regulatory spaces of any substance in America. It's not FDA-approved for any medical use. It's not a controlled substance at the federal level. It's not legal everywhere. And the agencies responsible for drug policy can't seem to agree on what to do about it.

Understanding this regulatory landscape matters — not just for legal reasons, but because it directly affects product safety, research availability, and your ability to make informed decisions about what you're putting in your body.

The FDA's Position

The Food and Drug Administration has been consistently hostile toward kratom. Their official position, maintained across multiple administrations, includes several key claims:

"Kratom Is an Opioid"

The FDA's computational analysis (using their Public Health Assessment via Structural Evaluation, or PHASE model) concluded that kratom's alkaloids have opioid properties. While this is pharmacologically accurate — kratom does act on opioid receptors — critics argue the FDA overstates the comparison to classical opioids while downplaying the significant pharmacological differences.

"Kratom Has No Proven Medical Use"

Since kratom hasn't been through FDA clinical trials, the agency maintains there's no evidence it's safe or effective for any medical purpose. This creates a catch-22: research is difficult to conduct because of regulatory barriers, and the lack of research is used to justify those barriers.

Import Alerts

Since 2014, the FDA has maintained Import Alert 54-15, which gives customs agents authority to detain kratom shipments entering the US. This doesn't affect domestic sales of kratom already in the country, but it restricts the supply chain and has been used to seize large shipments.

Adverse Event Reports

The FDA has linked kratom to dozens of deaths, though the vast majority of these cases involved other substances (alcohol, prescription drugs, illicit opioids) in combination with kratom. Pure kratom-only deaths are extremely rare in the medical literature, but the FDA's reporting doesn't always make this distinction clear.

The DEA Scheduling Attempt (2016)

The most dramatic moment in kratom regulation came in August 2016, when the Drug Enforcement Administration announced its intent to emergency schedule kratom as a Schedule I controlled substance — the same category as heroin and LSD.

The response was unprecedented:

• Over 140,000 people signed a White House petition opposing the ban
• 51 members of the U.S. House and 9 senators wrote letters to the DEA protesting the decision
• Scientists, researchers, and public health advocates submitted formal comments arguing that scheduling would push users to more dangerous alternatives and hinder research

In October 2016, the DEA withdrew its notice of intent — one of the very few times the agency has backed down from a scheduling action. For more on the legal history, see our kratom legal status page.

State-Level Regulation

While federal scheduling has been blocked, several states have taken action independently:

States Where Kratom Is Banned

• Alabama — Schedule I since 2016
• Arkansas — Schedule I since 2016
• Indiana — Banned since 2014
• Tennessee — Banned synthetic kratom alkaloids (interpreted broadly)
• Vermont — Regulated as a controlled substance
• Wisconsin — Banned mitragynine and 7-hydroxymitragynine

The Kratom Consumer Protection Act (KCPA)

Several states have taken a different approach — passing the Kratom Consumer Protection Act, a model bill that regulates kratom rather than banning it. The KCPA typically requires:

• Age verification (21+ in most versions)
• Product labeling with alkaloid content
• Contamination testing
• Bans on adulterated products

States that have passed some form of KCPA include Arizona, Georgia, Nevada, Oregon, and Utah, among others. This approach is increasingly seen as the pragmatic middle ground between prohibition and zero regulation.

Why Regulation Matters for You

If you're using kratom — or thinking about quitting — the regulatory situation affects you in several ways:

Product Safety

Without federal regulation, there are no mandatory standards for kratom products. This means:

• No required testing for contaminants (heavy metals, bacteria, pesticides)
• No standardized labeling of alkaloid content
• No verification that what's on the label matches what's in the product
• Risk of adulterated products that may contain undisclosed substances

Research Limitations

The regulatory ambiguity has chilled research. Scientists who want to study kratom face bureaucratic hurdles, funding challenges, and the risk that their subject could be scheduled at any time. This means we have less clinical data on kratom than we should — which hurts both users and policymakers.

Access to Help

In states where kratom is banned, users may be less willing to seek medical help for dependence because they fear legal consequences. Even in legal states, the stigma around kratom's quasi-legal status can prevent people from being honest with their doctors.

What's Likely Coming

Based on current trends, here's what the regulatory future probably looks like:

1. Federal scheduling remains unlikely in the near term — the political backlash from 2016 made regulators cautious, and the kratom advocacy community remains vocal
2. More states will pass consumer protection acts — the KCPA approach is gaining momentum as a regulatory model
3. Extract regulation may emerge — concentrated kratom extracts and 7-OH products are drawing increasing regulatory attention due to their higher potency
4. Research will slowly increase — NIH has funded some kratom research, and academic interest is growing
5. Age restrictions will become more common — even kratom advocates generally support keeping it away from minors

The Bottom Line

Kratom's regulatory status is messy, and it's unlikely to be fully resolved anytime soon. What this means for you: don't rely on legal status as a proxy for safety. Something being legal doesn't make it harmless — alcohol is legal too, and nobody would call it safe.

Make your decisions based on the pharmacology, the evidence of harm, and your own experience — not on whether Congress has gotten around to regulating it yet.

The information on this website is for educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.